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Several lifestyle factors play a signiﬁcant role in determining an individual’s risk of breast cancer. Many of them could be modiﬁed
to protect against the malignancy. A nested case-control study was conducted to examine the association between selected lifestyle
factors and non-BRCA-related breast cancer risk among French-Canadian women. Some 280 women with breast cancer and who
were nongene carriers of mutated BRCA gene were recruited as cases. Another 280 women, without any cancer and nongene
carriers of mutated BRCA gene served as controls. A tested lifestyle questionnaire was interviewer administered to incident cases
to obtain information on weight history, smoking, physical activity, and other lifestyle risk factors. Odds ratios (ORs) and 95%
conﬁdence intervals (CIs) were estimated in logistic regression models. Comparing cases to controls, breast cancer risk was higher
among subjects who reached their maximum body mass index (BMI) at an older age (>50 years) (OR = 2.83; 95% CI: 2.34–2.91).
A positive association was noted between breast cancer risk and weight gain of >34lbs compared to weight gain of ≤15lbs, since
the age of 20 (OR = 1.68; 95% CI: 1.10–2.58). Weight gain of >24lbs compared to weight gain of ≤9lbs, since the age of 30 also
resulted in the same relationship (OR = 1.96; 95% CI: 1.46–3.06). Similarly, since the age of 40, weight gain of >12lbs compared
to weight gain of ≤1 lb was associated with increased breast cancer risk (OR = 1.91; 95% CI: 1.53–2.66). Women who smoked
>9 pack-years of cigarettes had a 59% higher breast cancer risk (P = .05). Subjects who engaged in >24.8 metabolic-equivalent-
(MET-) hours per week compared to ≤10.7 MET-hours per week of moderate physical activity had a 52% (P = .01) decreased risk
and total physical activity between 16.2 and 33.2 MET-hours per week compared to ≤16.2 MET-hours per week, resulted in a 43%
(P = .05) lower risk of breast cancer. In conclusion, weight history did aﬀect breast cancer risk. Moreover, smoking appeared to
raise the risk, whereas moderate physical activity had a protective eﬀect.
Copyright © 2009 Vishnee Bissonauth et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Breastcancerwasthesecondmaincauseofallcausesofdeath
among Canadian womenin 2007 [1–3]. Itisnow known that
germline mutations in the BRCA breast cancer susceptibility
gene increase susceptibility to breast and ovarian cancers,
with an average cumulative risk for breast cancers by the
a g eo f7 0o f6 5 %i nBRCA1-mutation carriers and of 39%
in BRCA2 mutation carriers [4]. Several lifestyle factors
may play a signiﬁcant role in determining an individual’s
risk of breast cancer and could be modiﬁed to protect
against development of malignancy. For example, obesity,2 Journal of Cancer Epidemiology
a serious public health problem that is reaching epidemic
proportions in many countries, signiﬁcantly contributes
to the development of certain cancers, including breast
cancers [5]. Although anthropometric characteristics have
been evaluated as possible determinants of breast cancer risk
[6,7],studiesontheassociationofobesity withbreastcancer
risk in Western women have led to contradictory results. In
addition,amongcommonly-studiedlifestylefactors,physical
activity has been the focus of numerous investigations. A 3%
decrease in breast cancer risk has been observed for each
1-hour increase per week in recreational physical activity
duringadolescence,[8].Indeed,arecentstudyhasconcluded
that there is an increased risk for development of breast
cancer in the presence of obesity and low levels of physical
activity [9]. Likewise, smoking plays a highly signiﬁcant role
in cardiovascular and respiratory disease as well as in lung
cancer and could aﬀect breast cancer risk. However, the
evidence is contradictory [5], and a collaborative reanalysis
of the evidence from 53 epidemiological studies worldwide
found that smoking had little or no independent eﬀect
on the risk of women developing breast cancer [10]. Most
studies to date have addressed the relationship between
lifestyle factors and breast cancer risk among sporadic cases
or gene mutation carriers. To our knowledge, this is the
ﬁrst study which has addressed the issue in a speciﬁc
population such as French Canadians, a group with a
shared, speciﬁc genetic background and relatively more
common BRCA mutations. Because it is currently not
known whether lifestyle inﬂuences breast cancer risk in
BRCA nongene carriers, we undertook the present study to
examine associations between selected lifestyle factors and
breastcancerriskamongFrench-Canadianwomenwhowere
noncarriers of the 6 more frequent founder mutations of
BRCA1/2.
2.MaterialsandMethods
2.1. Study Population. The study subjects were identiﬁed
from participants in an ongoing genetic breast cancer study,
which began recruitment in 2004. Breast cancer patients
who attended the Breast Center of Centre Hospitalier de
l’Universit´ ed eM o n t r ´ eal (CHUM) Hotel-Dieu were invited
to participate during a follow-up appointment. They were
French-Canadian women (those who were born in the
province of Qu´ ebec and having a maternal or paternal origin
from the descendants of French origins who had settled in
Canada) with early-onset breast cancer. Early onset of breast
cancer is as breast cancer occurring at a younger age, without
metastasis and considered to be disease with a large inherited
component, that is, stemming from a mutation passed on
from parent to child. In this study, cases who were ≤50
yearsoldatdiagnosis,withnon-BRCArelatedinvasivebreast
cancer, were eligible for the study, while those with in situ
breast cancer had to have a positive family history of breast
cancer or ovarian cancer to be eligible for this study. Cases
>50 years old with invasive or in situ breast cancer had to
have a positive family history of breast or ovarian cancer to
be eligible for this study.
The diagnosis of breast cancer was conﬁrmed by review
of pathology reports and medical records by physicians and
geneticists at the Chair of Breast Cancer of the Research
Center of University of Montreal (RC-CHUM).
For the current study, cases and controls were tested
for founder mutations. These women also provided written
consent for BRCA gene testing, designed to detect the
presence of 6 speciﬁc mutations found more frequently in
families of French-Canadian descent [11]. A DNA-based
test was conducted to identify any of 6 founder mutations
in BRCA1 or BRCA2. These 6 mutations (BRCA1 3875del-
GTCT, BRCA1 2953delGTAinsC, BRCA1 C4446T, BRCA2
8765delAG, BRCA2 3398delAAAAG, BRCA2 6085G > T)
account for approximately 85% of all BRCA mutations in
the French-Canadian population. If they were not carriers of
these mutations, they became eligible cases for this study.
Eligible cases were identiﬁed and interviewed, in order
to construct a computerized pedigree and obtain informa-
tion regarding sociodemographic characteristics and breast
cancer risk factors. The inclusion criteria for cases stipulated
that subjects must be French-Canadian women of all ages,
recruited by the research team of the Epidemiology Research
Unit of RC-CHUM from 2004–2006, noncarriers of any
of the 6 founder mutations mentioned above, and having
primary breast cancer without metastasis. The exclusion
criteria for cases were non-French-Canadian women, being
too ill to answer the questionnaires and aﬀected by cancers
other than breast cancer.
Some 285 noncarriers of these mutations with breast
cancer (all ages) were selected sequentially until the target
sample was achieved, from the mentioned above cohort
of 513 French-Canadian women diagnosed from 2004 to
2006. Of these women, 2 cases (0.7%) refused to participate
after being contacted, and 3 subjects (1%) changed their
address and were unreachable at the time of data collection.
Therefore 280 eligible cases (98%) were interviewed.
Control subjects were women from families with breast
cancer (n = 265), except for 15, (5.4%) who came from the
same families as cases. Of these: 8 had a sister-sister rela-
tionship; 4 had an aunt-niece relationship; 2 had a mother-
daughter relationship; 1 had a grandmother-granddaughter
relationship (see Table 5).
The inclusion criteria for controls were as follows:
French-Canadianwomenofallages,recruitedatRC-CHUM,
subjects not carrying any of the 6 founder mutations
mentionedaboveandfreefromcancer.Theexclusioncriteria
forcontrolswerenon-French-Canadianwomen,beingtooill
to answer the questionnaires and aﬀected by cancer.
They were matched for age group (by 10-year age
intervals) to cases. A total of 300 eligible controls were
identiﬁed, of whom 13 (4%) were unreachable, and 7 (2%)
refused to participate after the study was explained to them.
In all, 280 eligible control subjects (93%) were interviewed.
2.2. Assessment of Lifestyle Factors. To assess weight history,
participants were asked about their current weight and their
weight when they were 20, 30, and 40 years old. TheyJournal of Cancer Epidemiology 3
Table 1: Selected characteristics of the study population.
Variables Cases (n = 280) (%) Controls (n = 280) (%) P value
1
Age (years, mean ± SD) 51.9 ±8.25 0 .0 ±9.8. 0 1
<30 3 4
31–40 17 27
41–50 45 41
51–60 29 23
61+ 6 5
Education attainment (years, mean ± SD) 13.4 ±3.01 2 .8 ±3.1. 0 1
Marital status
Single 12.5 11.1
Married/Common-law 70.4 66.4
Separated/divorced 13.9 14.6
Widowed 3.2 7.9 .15
Parity
Nulliparous 27.1 15.4 .01
≥1 72.9 84.6 .01
Menopausal status
Yes 203 145
No 77 135 .01
Oral contraceptive use
Ever 87.9 85.0
Never 12.1 15.0 .40
Hormone replacement therapy
Yes 26.8 33.6
No 73.2 66.4 .10
Smoking
Ever 63.6 53.6
Never 36.4 46.4 .02
Smoking 10.3 ±13.47 .8 ±12.8. 0 3
(pack-years, mean ± SD)
Age at menarche (years, mean ± SD) 12.5 ±1.51 2 .7 ±1.6. 1 2
Age at menopause (years) 45.4 ±6.94 5 .3 ±7.9. 2 0
Age at maximum weight (years) 46.6 ±11.93 9 .4 ±12.5. 0 1
Current weight (lbs) 146.6 ±25.3 143.1 ±25.1. 1 0
Weight at the age of 20 (lbs) 116.7 ±16.0 119.9 ±19.7. 0 6
Weight at the age of 30 (lbs) 129.9 ±21.0 127.4 ±14.8. 1 8
Weight at the age of 40 (lbs) 141.8 ±28.1 137.4 ±29.8. 2 0
Maximum lifetime weight (lbs) 155.8 ±26.4 149.9 ±28.5. 0 4
Weight gain since the age of 20 (lbs) 30.0 ±22.62 3 .2 ±21.8. 0 1
Weight gain since the age of 30 (lbs) 21.3 ±20.41 5 .0 ±18.7. 0 1
Weight gain since the age of 40 (lbs) 12.4 ±14.96 .9 ±15.2. 0 1
Physical activity (MET-hours/week)
Moderate (4) 18.8 ±13.52 1 .8 ±14.8. 0 1
Vigorous (7) 8.1 ±12.07 .1 ±11.0. 2 9
Total 26.9 ±20.02 8 .9 ±18.8. 2 2
Total energy intake (Kcal) 2025.6 ±674.2 1782.1 ±626.3. 0 1
1All P values are univariate and derived by student’s t-test for continuous variables with the χ2 test for categorical variables.
MET: metabolic equivalent.
were also asked to give their highest weight (excluding
pregnancies) as well as their age at their highest weight.
To evaluate participation in sports activities or physical
exercise 2 years prior to diagnosis (cases) or interview
(controls), the study subjects were asked in which seasons,
howoften,andtheaveragedurationpersessiontheyengaged
ineachofthe12mostcommontypesofleisure-timephysical
activities in Canada. This section of the questionnaire was4 Journal of Cancer Epidemiology
Table 2: Odd ratios and 95% conﬁdence intervals for breast cancer risk associated with weight history.
Variables Q1 Q2 Q3 P for trend
Current BMI
∗
Range (kg/m2) ≤21.1 >21.1 and ≤25.0 >25.0
Cases/Controls 91/92 98/94 91/94
Univariate OR (95% CI) 1.00 1.34 (0.35–1.41) 1.76 (0.91–1.78) .08
Multivariate OR
a (95% CI) 1.25 (0.76–1.85) 1.55 (0.77–1.89) .09
Age at maximum BMI
Range (years) ≤39 >39 and ≤50 >50
Cases/Controls 58/126 108/94 114/60
Univariate OR (95% CI) 1.00 2.50 (1.65–3.78) 2.65 (2.60–3.41) .01
Multivariate OR
a (95% CI) 2.77 (1.76–4.85) 2.83 (2.34–2.91) .01
Weight gain since the age of 20
Range (lbs) ≤15 >15 and ≤34 >34
Cases/Controls 80/115 93/78 107/87
Univariate OR (95% CI) 1.00 1.71 (1.13–2.60) 1.67 (1.18–2.64) .01
Multivariate OR
a (95% CI) 1.76 (1.13–2.72) 1.68 (1.10–2.58) .01
Weight gain since the age of 30
Range (lbs) ≤9 >9a n d≤24 >24
Cases/Controls 68/117 106/84 106/79
Univariate OR (95% CI) 1.00 2.31 (1.52–3.50) 2.17 (1.44–3.28) .01
Multivariate OR
a (95% CI) 2.25 (1.75–3.49) 1.96 (1.46–3.06) .01
Weight gain since the age of 40
Range (lbs) ≤1 >1a n d≤12 >12
Cases/Controls 55/120 80/63 103/60
Univariate OR (95% CI) 1.00 1.95 (1.16–2.74) 1.99 (1.47–2.49) .01
Multivariate OR
a (95% CI) 1.82 (1.36–3.10) 1.91 (1.53–2.66) .01
∗BMI at interview.
aAdjusted for age, education, physical activity, smoking, alcohol consumption and total energy intake.
developed and used over more than 10 years of studies on
cancer epidemiology by the Epidemiology Research Unit,
CHUM-Hˆ otel-Dieu. Physical activities included walking,
jogging or running, gardening or yard work, housework,
golf, tennis, bowling or curling, swimming or water exer-
cise, skiing or skating, bicycling, social dancing and other
strenuous exercise. They indicated their usual frequency of
participation in each of the above-mentioned activities by
choosing 1 of the following categories: never, less than once
per month, 1–3 times per month, 1-2 times per week, 3–6
times per week or every day. The average time per episode
for each of the 12 activities included less than 15, 15–
30, 31–60 minutes, and more than 60 minutes. Intensity
was categorized as moderate or vigorous, and classiﬁcation
was based on the amount of energy or eﬀort a participant
expended in performing the activity [12]. Overall, physical
activity exposure was quantiﬁed in terms of metabolic
equivalents (MET), representing the number of kilocalories
perhoureachkilogramofbodyweightexpendedinactivities
[12]. MET-hours per week for each activity were computed
bymultiplying the METscorebyactivityduration. Moderate
physical activity was deﬁned as MET score of 4, and for
vigorous physical activity, it was deﬁned as 7 [12]. Finally,
total physical activity for each participant, as measured
by weekly MET-hours, was quantiﬁed by summing overall
intensity activities.
To assess smoking habits, the subjects were asked if
they ever smoked, and if they were currently smoking, their
age at smoking initiation, age at smoking cessation, and
average cigarettes consumption per day. A pack-year index
was computed by multiplying the total number of years
smoked by average consumption (in packs per day) over the
smoking period.
Menopausalstatuswasclassiﬁedaseitherpremenopause,
natural postmenopause, surgical post menopause, or
unknown, based on self-report of menstrual history. Age
at menopause was the age at last natural menstrual cycle
followed by one year of amenorrhea. For stratiﬁed analyses,
categories of premenopausal and postmenopausal that
included both natural and surgical menopausal groups
were used. Women with unknown menopausal status were
excluded from the stratiﬁed analyses.
For other lifestyle factors, the study subjects completed
an in person interviewer-administered core questionnaire
that included information regarding age, place of residence,
education, height, weight and history of weight change,
reproductive history, parity, breastfeeding, age at menarche,
oral contraception, hormone replacement therapy, maritalJournal of Cancer Epidemiology 5
Table 3: Odd ratios and 95% conﬁdence intervals for breast cancer risk associated with lifestyle factors, including smoking and physical
activity.
Variables Q1 Q2 Q3 P for trend
Smoking
Range (pack-years) ≤0 >0a n d≤9.0 >9.0
Cases/Controls 106/134 67/66 107/80
Univariate OR (95% CI) 1.00 1.28 (0.84–1.96) 1.69 (1.15–2.49) .03
Multivariate OR
a (95% CI) 1.35 (0.86–2.09) 1.59 (1.57–2.87) .05
Moderate physical activity
Range (MET-hours/week) ≤10.7 >10.7 and ≤ 24.8 >24.8
Cases/Controls 80/108 91/95 109/77
Univariate OR (95% CI) 1.00 0.68 (0.45–1.02) 0.52 (0.35–0.79) .01
Multivariate OR
b (95% CI) 0.67 (0.44–1.03) 0.48 (0.31–0.74) .01
Vigorous physical activity
Range (MET-hours/week) ≤0.11 >0.11 and ≤7.2 >7.2
Cases/Controls 91/94 91/92 98/94
Univariate OR (95% CI) 1.00 1.02 (0.68–1.54) 1.08 (0.72–1.61) .93
Multivariate OR
b (95% CI) 1.01 (0.66–1.56) 1.05 (0.66–1.52) .94
T o t a lp h y s i c a la c t i v i t y
Range (MET-hours/week) ≤16.2 > 6.2 and ≤33.2 >33.2
Cases/Controls 87/100 89/98 104/82
Univariate OR (95% CI) 1.00 0.69 (0.46–1.03) 0.72 (0.48–1.08) .14
Multivariate OR
b (95% CI) 0.57 (0.37–0.87) 0.66 (0.43–1.01) .05
aAdjusted for age, education, physical activity, alcohol consumption, and total energy intake.
bAdjusted for age, education, alcohol consumption, smoking, and total energy intake.
status, tamoxifen use and alcohol consumption. They also
completed an interviewer-administered 164-items semi-
quantitative food frequency questionnaire (FFQ) over the
telephone, on the possible role of diet in breast cancer risk,
which permitted the quantiﬁcation of alcohol consumption
in the etiology of breast cancer. The FFQ was developed by
the National Cancer Institute of Canada.
2.3. Statistical Analysis. Descriptive statistics were compiled
to characterize the study population and to examine case-
control diﬀerences. Demographic features and potential risk
factors between cases and controls were compared by t-test
for continuous variables and by the chi-square (χ2)t e s tf o r
categorical variables.
Conditional logistic regression analysis was used to com-
pute the odds ratios (ORs) and associated 95% conﬁdence
intervals (95% CIs) of breast cancer for the variables of
interest. Because of the limited sample size, only those
variables that were confounders in this dataset and for which
there was a strong biological rationale were considered. Two
setsofanalyseswereperformed.Intheﬁrstmodel,univariate
modeling was applied to identify potential confounding
variables. A P-value less than .05 was considered to be sta-
tistically signiﬁcant [13]. In the second model, multivariate
analysis was applied to control for confounding factors, and
these results are presented below. Variables considered as
confounders were age, education, physical activity, smoking,
alcohol consumption, and total energy intake. Lifestyle
variables were classiﬁed according to tertile distribution,
with the lowest tertile being the reference category. The
control group was used to create tertile cut points. Tests
for linear trend were undertaken, and dose-response trends
in risk calculation were evaluated for all analyses by ﬁtting
the continuous variable into the model with Wald values
[14]. Tests for linear trend were performed by replacing the
indicator lifestyle variable in each multivariate model with a
singlevariablerepresentingthemedianvalueoftheindicator
variable for a given category and by using the Wald X2 value
calculated for the regression coeﬃcient of this variable to test
the null hypothesis of no linear trend component in non-
BRCA related breast cancer risk across tertiles. All tests were
2-sided.
Models were run separately for both pre- and post-
menopausal women and were adjusted for age. Women were
considered as postmenopausal if they reported having no
menstrual periods at least 1 year before data collection.
3. Results
3.1. Characteristics of Study Subjects. Selected characteristics
of cases and controls are summarized in Table 1.M e a n
(±SD)ageofthecaseswas51.9±8.2yearsand50.0±9.8years
for the controls (P = .01). Diﬀerences in age distribution
were noticeable between cases and controls with a slight
excess of younger control subjects. Cases had signiﬁcantly
higher education levels than the controls (P = .01). The
nulliparous rate of the cases was signiﬁcantly higher than
that of the controls (P = .01), and cases also had fewer6 Journal of Cancer Epidemiology
Table 4: Multivariable adjusted odd ratios and 95% conﬁdence intervals for breast cancer risk in relation to BMI, weight gain, smoking, and
physical activity, by menopausal status.
Variable Premenopausal Postmenopausal
Cases/Controls OR (95% CI) Cases/Controls OR (95% CI)
Current BMI (kg/m2)∗
≤22.5 20/45 1.0a 64/56 1.0a
>22.5 and ≤26.0 30/47 1.37 (0.96–2.60) 68/50 1.65 (0.96–2.70)
>26.0 27/43 1.02 (0.52–2.07) 71/39 1.19 (0.92–2.01)
P for trend .56 .35
Weight gain (lbs) from the age of 30 to the age of 40
≤13 27/49 1.0a 65/49 1.0a
>13 and ≤25 25/40 1.55 (0.81–1.86) 70/51 1.95 (0.88–2.17)
>25 25/46 1.62 (1.42–1.97) 68/45 1.98 (1.11–2.03)
P for trend .05 .03
Weight gain (lbs) from the age of 40 to the age of 50
≤13 66/52 1.0a
>13 and ≤25 67/55 2.01 (0.74–2.80)
>25 70/38 2.01 (1.45–2.91)
P for trend .04
Weight gain (lbs) from the age of 50 to the age of 60
≤13 69/50 1.0a
>13 and ≤25 71/47 1.86 (0.62–1.97)
>25 63/48 1.79 (1.21–2.33)
P for trend .03
Smoking (pack-years)
≤0 17/41 1.0b 62/55 1.0b
>0a n d≤9 31/45 1.30 (0.76–1.86) 70/47 1.62 (0.90–1.93)
>9 29/49 1.63 (1.23–2.47) 71/43 1.49 (1.33–2.31)
P for trend .05 .04
Moderate physical activity (MET-hours/week)
≤10.7 25/40 1.0c 69/45 1.0c
>10.7 and ≤24.8 32/47 0.57 (0.26–1.60) 60/53 0.65 (0.96–1.71)
>24.8 20/48 0.36 (0.22–0.67) 74/47 0.42 (0.12–0.59)
P for trend .02 .03
Vigorous physical activity (MET-hours/week)
≤0.11 27/43 1.0c 68/50 1.0c
>0.11 and ≤7.2 26/45 0.97 (0.56–1.64) 62/47 1.05 (0.46–1.73)
>7.2 24/47 1.02 (0.71–1.57) 73/48 0.99 (0.72–1.91)
P for trend .76 .95
Total physical activity (MET-hours/week)
≤16.2 26/44 1.0c 67/49 1.0c
>16.2 and ≤33.2 25/46 0.70 (0.46–1.24) 70/52 0.65 (0.46–1.83)
>33.2 26/45 0.63 (0.41–0.97) 66/44 0.89 (0.35–0.91)
P for trend .05 .05
∗BMI at interview.
aAdjusted for age, education, physical activity, smoking, alcohol consumption, and total energy intake.
bAdjusted for age, education, physical activity, alcohol consumption, and total energy intake.
cAdjusted for age, education, alcohol consumption, smoking, and total energy intake.
children than the controls (P = .01). There were more
postmenopausal women among the cases than the controls
(P = .01), perhaps due to the above mentioned diﬀerent
age distribution among cases and controls. The cases were
signiﬁcantly more likely to have smoked at any time in their
lives than the controls (P = .03). The controls were more
likely to have reached their maximum lifetime weight at
an earlier age (39 years) than the cases (47 years) (P =
.01), while history of weight change indicated that the cases
had signiﬁcantly higher maximum lifetime weight than theJournal of Cancer Epidemiology 7
Table 5: Matched cases and controls by relationship: 15 subjects.
Age of diagnosis of
breast cancer cases
(index cases)
Age of controls (relatives) at interview
Relationship
Sister-sister:
54 74
54 58
42 45
60 50
39 48
39 49
39 51
35 41
S u bt o t a lo fs u b j e c t s :8
Aunt-niece
50 67
39 31
50 29
42 30
S u bt o t a lo fs u b j e c t s :4
Mother-daughter
35 50
62 44
S u bt o t a lo fs u b j e c t s :2
Grandmother-
granddaughter
62 23
S u bt o t a lo fs u b j e c t s :1
Grand total of subjects: 15
controls(155.8v/s149.9)(P = .04).Higherweightgainsince
adolescence and adulthood was observed among cases than
the controls (P = .01). Controls practiced more moderate
physical activity than the cases (P = .01). The cases were
more likely to have greater total energy intake (P = .01) and
alcohol (ethanol) intake (P = .03) than the controls, whereas
no diﬀerence was apparent between study groups in the use
oforalcontraceptivesandhormonereplacementtherapy,age
at menarche and at menopause, current weight, weight at
the age of 20, 30, and 40, and vigorous and total physical
activity.
3.2. Weight History. The risk of breast cancer in relation
to weight history is presented in Tables 2 and 4 reporting
the results stratiﬁed by menopausal status. After adjust-
ing for age, education, physical activity, smoking, alcohol
consumption, and total energy intake, breast cancer risk
was increased when subjects reached their maximum body
mass index (BMI) at an older age (>50 years) (OR = 2.83;
95% CI: 2.34–2.91). In addition, a positive association was
noted between maximum weight gain of more than 34 lbs
compared to weight gain of ≤15lbs, since age 20 (OR =
1.68; 95% CI: 1.10–2.58). Weight gain of more than 24lbs
compared to weight gain of ≤9lbs since the age of 30 also
showed similar results (OR = 1.96; 95% CI: 1.46–3.06).
Likewise, a positive association with breast cancer risk (OR
= 1.91; 95% CI: 1.53–2.66) was observed for a weight gain
after the age of 40 of more than 12lbs compared to a weight
gain of ≤1lb. Weight gain of more than 25lbs from the age
of 30 to the age of 40 presented an increased risk of breast
cancer in both pre- (OR = 1.62; 95% CI: 1.42–1.97) and
postmenopausal women (OR = 1.98; 95% CI: 1.11–2.03).
Weight gain of more than 25lbs from the age of 40 to the
age of 50 presented an increased risk of breast cancer in
postmenopausal women (OR = 2.01; 95% CI: 1.45–2.91) as
well as weight gain of more than 25lbs from the age of 50
to the age of 60 showed an increased risk of breast cancer
in postmenopausal women (OR = 1.79; 95% CI: 1.21–2.33).
No association was apparent between breast cancer risk and
current BMI, and BMI at the age of 20, 30, 40, under 49, and
over 50 years. Furthermore, maximum lifetime BMI did not
show any signiﬁcant association with breast cancer risk (data
not reported).
3.3. Lifestyle Factors
3.3.1. Smoking. The ORs and 95% CIs for breast cancer
risk by smoking status for all age groups are enumerated
in Table 3; these results also appear in Table 4, where they
are stratiﬁed by menopausal status. After adjusting for age,
education, physical activity, alcohol consumption and total
energy intake, women who smoked more than 9 pack-
years had a 59% greater risk of breast cancer (OR = 1.59;
95% CI: 1.57–2.87) (Table 3). A 63% higher risk of breast
cancer was also noted among premenopausal women (OR =
1.63; 95% CI: 1.23–2.47), with a 49% increased risk among
postmenopausal women (OR = 1.49; 95% CI: 1.33–2.31)
(Table 4).
3.3.2. Physical Activity. Women who practiced >24.8 MET-
hours compared to ≤10.7 MET-hours of moderate physical
activity weekly had a 52% lower risk of breast cancer
(OR = 0.48; 95% CI: 0.31–0.74) (Table 3). Moreover, total
physical activity between 16.2 and 33.2 MET-hours per
week compared to ≤16.2 MET-hours per week also showed
a 43% decreased risk of breast cancer (OR = 0.57; 95%
CI: 0.37–0.87), and for >33.2 MET-hours per week, there
was a nonsigniﬁcantly reduced risk (OR = 0.66; 95% CI:
0.43–1.01). A protective eﬀe c to fm o d e r a t ep h y s i c a la c t i v i t y
of more than 24.8 MET-hours per week was observed among
both premenopausal (OR = 0.36; 95% CI: 0.22–0.67) and
postmenopausal women (OR = 0.42; 95% CI: 0.12–0.59). A
similar outcome was noted for total physical activity of more
than 33.2 MET-hours per week for both premenopausal (OR
= 0.63; 95% CI: 0.41–0.97) and postmenopausal women
(OR = 0.88; 95% CI: 0.35–0.91) (Table 4). However, no
statistically signiﬁcant association was apparent between
vigorousphysicalactivity(>7.2MET-hours/week)andbreast
cancer risk, regardless of menopausal status.8 Journal of Cancer Epidemiology
4. Discussion
The present case-control study provides results on lifestyle
factors and breast cancer risk among French-Canadian
women who are noncarriers of the 6 most frequent BRCA1/2
mutations in this population. To our knowledge, this is the
ﬁrst epidemiological investigation to assess the possible role
of common lifestyle variables in the etiology of breast cancer
in such a sample. Previous research on lifestyle and breast
cancer risk has been mostly undertaken on either sporadic
subjects or among BRCA mutation carriers.
Our ﬁndings concur with previous work reporting that
weight gain since youth is related to increased sporadic
breast cancer risk [15–19]. Our results also demonstrate
that weight gain has a stronger positive association among
postmenopausal than premenopausal women. A recent case-
control study of changes in body weight and the risk of
breast cancer in BRCA mutation carriers reported that
among BRCA1 mutation carriers, a weight gain of more
than 10lbs between the age of 18 and 30 was associated
with a 44% greater risk of breast cancer diagnosed between
the age of 30 and 40 [20]. Moreover, these results bolster
those of our research group’s recent case-control study of
a group of French-Canadian BRCA carriers, indicating that
weight gain from the age of 18 and 30 was positively
associated with breast cancer risk [21]. On the other hand,
recent prospective data from the Black Women’s Health
Study suggested that weight gain in this population was
not linked with postmenopausal breast cancer risk providing
evidence for diﬀerential results in other ethnic populations.
The ﬁndings also indicated that BMI ≥25 at the age
of 18 of relative to <20 was associated with 32% and
47% reduced risks of breast cancer among premenopausal
andpostmenopausalAfrican-Americanwomen,respectively,
[22]. A likely contributor to the discrepancy in ﬁndings
between Black and White women with regard to current
BMI, weight gain, and postmenopausal breast cancer risk is
the diﬀerence in distributions of estrogen receptor (ER) and
progesteronereceptor(PR)status.African-Americanwomen
have a considerably lower proportion of breast carcinomas
that are ER+,P R +, or both, than White women [22].
As women age, particularly after menopause, obese
women have a high level of serum estrogen as a consequence
of adrostenedione conversion to estrone in adipose tissue,
and also due to decreasing concentrations of sex hormone-
binding globulin that elevates serum free estrogen [23, 24].
High estrogen production may promote tumor growth. Our
study also found that age at attainment of maximum BMI
might be an important facet of body size when assessing
breast cancer risk. Understanding the importance of age as
a predictor of breast cancer risk involves consideration of
the inﬂuence of adipose tissue on estrogen production and
circulation, particularly postmenopause. From the onset of
menopause, adipose tissue becomes the primary estrogen
producer, and triacylglycerol and insulin levels rise simul-
taneously. The combination of these events is believed to
lengthen a woman’s exposure to more active estrogen [25,
26]. It has also been hypothesized that the eﬀects of obesity
may be stronger among older, postmenopausal women, due
to the longer period of time they are subjected to the
proliferative actions of elevated circulating estrogens from
adipose tissue. Indeed, a higher breast cancer risk among
older postmenopausal women compared to younger women
has been suggested by a pooled analysis of 7 prospective
studies [27]. Therefore, one may expect that women who
reach their maximum BMI later in life will be at greater risk
for breast cancer.
Our study showed that more than 9 pack-years of smok-
ing had a signiﬁcant positive association with breast cancer
risk among both pre- and postmenopausal women; however,
this result does not support our previous report of a reduced
risk of breast cancer in carriers of BRCA gene mutations
who had smoked more than 4 pack-years [28]. The weaker
breast cancer risk in these subjects may have been associated
with lower levels of circulating estrogens [29]. In contrast, a
recent case-control study among Polish women indicated an
increasedriskofinvasivebreastcancerwiththeconsumption
of ≥10 cigarettes/d among both premenopausal (OR = 2.55;
95% CI: 1.81–3.60) and postmenopausal (OR = 1.78; 95%
CI: 1.33–2.37) women [30]. Likewise, another recent study
[31]suggestedthatBRCAmutationcarrierswhosmokedhad
2.3-fold (95% CI: 1.6–3.5) and 2.6-fold (95% CI: 1.8–3.9),
respectively, greater risk of breast cancer. Cigarette smoke
contains compounds that damage DNA, and the repair of
such damage may be impaired in women with germline
mutations. Some genotoxic carcinogens in tobacco smoke
are mammary carcinogens in rodents [32]. The enzymatic
machinery required for their metabolic activation is present
in human mammary epithelial cells [33], and there is
evidence of carcinogen-DNA adducts in human mammary
tissue [34, 35], some of which may be smoking-related.
Finally, our study found that moderate physical activity
was related to a decreased risk of breast cancer regardless of
menopause status. Physical activity has received much atten-
tion for its salutary eﬀect on breast cancer risk, as it is one of
the few modiﬁable risk factors for breast cancer. Numerous
epidemiological investigations have reported a reduced risk
of breast cancer with increasing levels of physical activity
[36, 37]. In 2002, the International Agency for Research
on Cancer (IARC) concluded that “convincing” evidence
exists for an inverse association between breast cancer risk
and physical activity [38]. Our ﬁnding is also consistent
with most recent work in this ﬁeld. For instance in a case-
control study by Kamarudin et al. [39], inactive women had
a 3.5-fold signiﬁcantly higher breast cancer risk compared
to those who exercised regularly. Data from the California
Teachers Study [40] (110599 women, 2649 invasive and
593 in situ cases) also demonstrated a 20% reduction of
invasive, and 31% decrease of in situ, breast cancer risk
among women who exercised regularly >5h o u r s / w e e kp e r
year. The authors reported a linear diminution of risk with
escalating amounts of exercise. Recently, a population-based
case-control study in Massachusetts established that neither
lifetime recreational nor strenuous occupational physical
activity appeared to be associated with breast carcinoma
risk in situ. In contrast, recreational physical activity was
associatedwithareducedriskofinvasivebreastcancerinthis
investigation. After adjustment for potentially confoundingJournal of Cancer Epidemiology 9
factors, women averaging >6h o u r sp e rw e e ko fs t r e n u o u s
recreational activity over their lifetime had a 23% decrease in
the risk of invasive breast cancer when compared to women
reporting no recreational activity (95% CI: 0.65–0.92; P =
.05 for trend) [41].
Several biological mechanisms have been proposed to
explain the lower risk of breast cancer associated with phys-
ical activity. In adolescents and young women who are very
active, vigorous exercise is accompanied by delayed menar-
che, irregular and anovulatory menstrual cycles, and a short-
ened luteal phase [42–45]. Furthermore, postmenopausal
women who are physically active have lower levels of estrone
and estradiol [46–48]a sw e l la se l e v a t e ds e xh o r m o n e -
bindingglobulin[49].Higherestrogenandlowerlevelsofsex
hormone-binding globulin are associated with heightened
breast cancer risk in postmenopausal women [50]. Other
potential mechanisms include the prevention of weight gain,
regulation of insulin sensitivity, and alterations in immune
function [51–54].
Like all other case-control investigations, the present
study has certain limitations. While retrospective measures
may result in recall bias, such a problem is likely to be
minimized since the same method served to collect infor-
mation from cases and controls. Moreover, the likelihood
of obtaining false information on maximum lifespan weight
and age when this weight occurred can be discounted, as
weight gain for a majority of women is a constant concern,
and they can recall their highest weight and its timing with
relatively good precision [21]. As with most case-control
studies, selection and recall bias may have inﬂuenced our
results.
The present work has a number of strengths. A major
strength is its population-based design, which included only
incident cases who had undergone genetic testing for 6
speciﬁc BRCA gene mutations more frequently found in
French-Canadian families and who provided full informa-
tion about known breast cancer risk factors. In addition,
the response rate for both cases and controls was high (over
90%),suggestingthatthepotentialforselectionbiaswaslow.
The main protective eﬀects exerted by certain lifestyle
factors identiﬁed in this paper are consistent with current
recommendations by the American Cancer Society for breast
cancer prevention [55, 56]. Because of the multifactorial
process in breast cancer development, and the tendency for
lifestyle variables to cluster, inconsistent and inconclusive
data have emerged on breast cancer risk even from well-
designed epidemiological research. Consequently, it is essen-
tial to continuously update knowledge on the risk factors
and their impact on breast cancer. This could help women
make beneﬁcial changes in their behavior by addressing diet
and physical activity patterns that could reduce their breast
cancer risk. In such a context, it is interesting that recent
evidence suggests that more than 50% of cancer incidence
couldbepreventedifknowledgeofriskfactorswasappliedto
changes in behavior [57]. The ultimate goal of such research
istocontributetonovelpreventionstrategiesandtodecrease
the number of women at risk for developing breast cancer.
In summary, we found that weight history did aﬀect
breast cancer risk. Moreover, smoking appeared to raise the
risk, whereas moderate physical activity had a protective
eﬀect. Further research is warranted to conﬁrm these asso-
ciations in other study populations and hopefully in larger
sample sizes.
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